Chronic myeloproliferative diseases. 3: Osteomyelofibrosis
Zankovich, R.
Fortschritte der Medizin 107(34): 736-740
1989
ISSN/ISBN: 0015-8178 PMID: 2606419 Document Number: 341514
Document emailed within 1 workday
Related Documents
Zankovich, R. 1989: Chronic myeloproliferative diseases. 3: Osteomyelofibrosis Fortschritte der Medizin 107(34): 736-740Zankovich, R.; Thiele, J.; Mödder, B.; Steinberg, T.; Simon, K.G.; Fischer, R.; Diehl, V. 1988: So-called primary (idiopathic) osteomyelofibrosis/-sclerosis (OMF) within the scope of chronic myeloproliferative diseases. I. Initial clinical and histologic findings in 102 patients with special reference to early hyperplastic and advanced fibrosclerotic stages Medizinische Klinik 83(19): 617-628
Frey, B.M.; Rafii, S.; Crystal, R.G.; Moore, M.A. 1998: Adenovirus long-term expression of thrombopoietin in vivo: a new model for myeloproliferative syndrome and osteomyelofibrosis Schweizerische Medizinische Wochenschrift 128(42): 1587-1592
Zankovich, R. 1989: Chronic myeloproliferative diseases. 2: Polycythemia vera rubra Fortschritte der Medizin 107(33): 717-719
Fernández Rodríguez, M.N. 1971: Chronic myeloproliferative diseases. Clinical and cytogenetic study Sangre 16(2): 159-184
Bock, O. 2007: Molecular diagnosis of chronic myeloproliferative diseases and myelodysplastic syndromes Verhandlungen der Deutschen Gesellschaft für Pathologie 91: 140-153
Rukavitsyn, O.A.; Pop, V.P.; Seriakov, A.P. 2004: Choice of therapy and overall survival in patients with chronic myeloproliferative diseases Voprosy Onkologii 50(4): 435-439
Miller, J.B. 1976: Chronic myelocytic leukemia and the myeloproliferative diseases during the child-bearing years Journal of Reproductive Medicine 17(4): 217-224
Sokolova, M.A.; Khoroshko, N.D.; Tsvetaeva, N.V.; Semenova, E.A.; Kaplanskaia, I.B.; Frank, G.A.; Misiurin, A.V. 2010: Study of bone marrow microvessel density is one of the diagnostic approaches in patients with Ph-negative chronic myeloproliferative diseases Terapevticheskii Arkhiv 82(12): 47-51
Sánchez Fayos, J.; Prieto, E.; Chica Gullón, E. 1998: Chronic granulocytic leukemia (Ph+): among yesterday's myeloproliferative syndromes, today's chronic myeloid leukemias, and tomorrow's mature-element monocellular myelopathies Sangre 43(2): 121-126
Aulbert, E.; Fromm, H. 1990: Ferritin in myeloproliferative diseases Medizinische Klinik 85(3): 125-131
Steruská, M.; Hrubisko, M. 1977: Current concepts of myeloproliferative diseases Vnitrni Lekarstvi 23(7): 706-711
Kissová, J. 2019: Interferon-alpha in the treatment of myeloproliferative diseases Vnitrni Lekarstvi 65(11): 699-703
Adam, Z. 1993: Interferon-alfa in the treatment of myeloproliferative diseases Vnitrni Lekarstvi 39(12): 1210-1218
Iseki, T. 1993: Vitamin B12 and transcobalamin in chronic myeloproliferative disorders Rinsho Byori. Japanese Journal of Clinical Pathology 41(12): 1310-1321
Tefferi, A. 1999: Introduction: overview of chronic myeloproliferative disorders Seminars in Hematology 36(1 Suppl. 2): 1-2
Benöhr, H.C.; Kraft, R.; Waller, H.D. 1976: Reduced glutathione and enzyme activities in erythrocytes of various again myeloproliferative diseases Verhandlungen der Deutschen Gesellschaft für Innere Medizin 82 Pt 2: 1592-1595
Oppliger Leibundgut, E.; Horn, M.Peter.; Brunold, C.; Pfanner-Meyer, B.; Marti, D.; Hirsiger, H.; Tobler, A.; Zwicky, C. 2006: Hematopoietic and endothelial progenitor cell trafficking in patients with myeloproliferative diseases Haematologica 91(11): 1465-1472
Linkesch, W.; Gisslinger, H.; Ludwig, H.; Flener, R.; Sinzinger, H. 1985: Therapy with interferon (recombinant IFN-alpha-2C) in myeloproliferative diseases with severe thrombocytoses Acta Medica Austriaca 12(5): 123-127
Bonaccorso, R.; Teresi, M.; Gebbia, V.; Tambone Reyes, M.; Tinnirello, D.; Di Marco, P.; Citarrella, P.; Mansueto, S. 1989: Recombinant alpha 2 interferon in the treatment of chronic myeloproliferative disorders Journal of ChemoTherapy 1(4 Suppl): 1266-1268